Dipen Sangurdekar

Dipen has over 15 years of experience in academia and industry building novel methods, infrastructure and teams in biomedical data science and engineering. His work spans oncology and neuroscience drug development and translational research at leading biotech and pharmaceutical companies. Prior to joining KSQ, Dipen led the Computational Oncology team at Takeda Pharmaceuticals, which was the computational and data science partner for the preclinical and early clinical portfolio of the oncology business unit. Before Takeda, Dipen led translational bioinformatics efforts at bluebird bio, working on multiple gene and cell therapy clinical programs across severe genetic diseases and oncology. Prior to bluebird bio, Dipen held roles at Biogen, Sanofi and GE Global Research Center. He has a B.S. and Ph.D. in Chemical Engineering from UDCT, Mumbai and University of Minnesota respectively, did his postdoctoral training in John Storey’s group at Princeton University, and has a MBA from Babson College.